TTI:NYSETetra Technologies, Inc. Analysis
Data as of 2026-05-06 - not real-time
$9.86
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
TETRA Technologies is trading at $9.86, above its 20‑day SMA of $9.18 and 50‑day SMA of $8.76, with an RSI of 63.7 and a bullish MACD histogram of 0.056, indicating short‑term momentum. The price sits near the $8.21 support level and well below the $10.21 resistance, giving room for upside. Recent Q1 2026 results showed flat revenue of $156.3 M YoY but a non‑GAAP EPS of $0.06 that beat consensus, reinforcing the bullish technical picture. Analyst consensus is a “strong_buy” with a median target of $12.25, implying a 26.8 % upside. However, the trailing P/E of 164x dwarfs the industry average of 30.6x, reflecting severe earnings compression. Forward P/E contracts to 24.9x, suggesting earnings are expected to rebound. The company carries a net‑debt of roughly $189 M (debt‑to‑equity 78.5%) and free cash flow of only $0.22 M, highlighting balance‑sheet pressure. Volatility is elevated at 40 % over the past 30 days and beta exceeds 1.4, pointing to heightened market sensitivity. Volume trends are decreasing, which could limit liquidity in rapid moves. Margins remain thin (gross 30 %, operating 8 %, profit 1.2 %) and ROE is just 3 %, underscoring operational challenges. The oilfield‑services sector faces cyclical and regulatory headwinds, adding medium‑level sector and regulatory risk. Despite these concerns, the combination of bullish technicals, earnings beat, and a forward earnings outlook supports a cautiously optimistic stance. Investors should weigh the upside potential against the high valuation and debt load.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 7/10
Key Factors
- Q1 earnings beat expectations
- Bullish technical indicators (price above SMA, MACD bullish)
- High short‑term volatility and decreasing volume
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Forward P/E of ~25x indicating earnings recovery
- Analyst upside target of 26.8% over current price
- Strong momentum with RSI below overbought levels
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Elevated debt‑to‑equity and thin margins
- Cyclical oilfield‑services exposure
- Valuation remains high relative to current earnings
Key Metrics & Analysis
Financial Health
Revenue Growth-0.60%
Profit Margin1.16%
P/E Ratio164.3
ROE3.04%
ROA5.20%
Debt/Equity78.55
P/B Ratio4.7
Op. Cash Flow$84.6M
Free Cash Flow$224.5K
Industry P/E30.6
Technical Analysis
TrendBullish
RSI63.7
Support$8.21
Resistance$10.21
MA 20$9.18
MA 50$8.76
MA 200$7.78
MACDBullish
VolumeDecreasing
Fear & Greed Index90.36
Valuation
Target Price$12.50
Upside/Downside26.77%
GradeFair
TypeGrowth
Risk Assessment
Beta1.47
Volatility40.26%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.